NCT04208152View on ClinicalTrials.gov

A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

December 6, 2019

Primary Completion Date

August 4, 2020

Study Completion Date

August 4, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

anle138b

capsule containing excipient and anle138b

DRUG

Placebo

matching placebo capsule containing excipient

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

Sponsors

Collaborators (1)

Aptuit
All Listed Sponsors
collaborator

Quotient Sciences

INDUSTRY

collaborator

Aptuit

INDUSTRY

lead

MODAG GmbH

INDUSTRY

NCT04208152 - A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy Subjects | Biotech Hunter | Biotech Hunter